First approved by the FDA in 2000, NovoRapid generated 15.46 billion DKK ($2.18 billion USD) in sales in 2022
Available online at: Summary Keywords weight loss, nutrient intake, glucagon-like peptide-1 receptor agonists, nutrition, diet, dietary reference intakes Citation Johnson B, Milstead M, Thomas O, McGlasson T, Green L, Kreider R and Jones R (2025) Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study
At 1.0mg doses, you are drawing 0.60 mL per week, which significantly reduces the number of doses per vial
Continuous treatment preserves the metabolic and appetite-suppressing benefits you've worked to achieve
Updated searches were run on October 4, 2023, March 20, 2024, and May 29, 2024
But you wish if you could have a conversation, that's who it would be